HEARTMATE 3 LVAS IMPLANT KIT
Report
- Report Number
- 2916596-2022-10476
- Event Type
- Injury
- Date Received
- April 21, 2022
- Date of Event
- April 10, 2022
- Report Date
- April 21, 2022
- Manufacturer
- THORATEC CORPORATION
- Product Code
- DSQ
- UDI-DI
- 00813024013297
- PMA / PMN Number
- P160054
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KS
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
MANUFACTURER'S INVESTIGATION CONCLUSION: THE PUMP REMAINS IN USE SUPPORTING THE PATIENT. A CORRELATION BETWEEN THE DEVICE AND THE REPORT OF GASTROINTESTINAL (GI) BLEEDING COULD NOT BE CONCLUSIVELY DETERMINED. BLEEDING IS LISTED IN THE INSTRUCTIONS FOR USE AS A POTENTIAL ADVERSE EVENT THAT MAY BE ASSOCIATED WITH THE USE OF HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM. GI BLEEDING HAS BEEN PREVIOUSLY INVESTIGATED AND WILL CONTINUE TO BE MONITORED THROUGH QUALITY DATA REVIEWS, WHICH ARE CONDUCTED ON PRODUCTION AND POST PRODUCT SIGNALS TO EVALUATE IF PRODUCTS ARE CONFORMING TO PRODUCT REQUIREMENTS. NO FURTHER INFORMATION WAS PROVIDED. THE MANUFACTURER IS CLOSING THE FILE ON THIS EVENT.
IT WAS REPORTED THAT THE PATIENT EXPERIENCED MELENA ON (B)(6) 2022; WARFARIN WAS WITHHELD UNTIL (B)(6) 2022. THE PATIENT VISITED THE EMERGENCY ROOM ON (B)(6) 2022 DUE TO POOR ORAL INTAKE AND DECREASED MENTAL STATUS. THE PATIENT WAS DIAGNOSED WITH HYPOVOLEMIC SHOCK. AN UPPER GASTROINTESTINAL ENDOSCOPY (EGD) AND SIGMOIDOSCOPY (SFS) WERE PERFORMED TO RULE OUT A GASTROINTESTINAL (GI) BLEED, AND BLOOD AND PLASMA TRANSFUSIONS WERE PERFORMED. A SOURCE OF THE PATIENT'S BLEEDING COULD NOT BE IDENTIFIED. THE PATIENT'S CONDITION WAS IMPROVING FOLLOWING THE TRANSFUSIONS AND THE EVENT WAS CONSIDERED RESOLVED ON (B)(6) 2022.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1772069 | HEARTMATE 3 LVAS IMPLANT KIT | VENTRICULAR (ASSISST) BYPASS | DSQ | THORATEC CORPORATION | 106524US | 8011941 | 00813024013297 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 76 YR | Female | Required Intervention| H |